Global Cardiac Resynchronization Therapy (CRT Devices) Market, 2012-2023

January 2018 | 209 pages | ID: G97CB9EF3EAEN
Precision Business Insights (PBI)

Abstracts

Cardiac Resynchronization Therapy Market

Cardiac Resynchronization therapy is used to treat heart diseases. Devices that are used in cardiac resynchronization therapy known as CRT devices. Irregular heartbeats is known as arrhythmias that can be caused due to the various reasons such as age, damage of heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with the arrhythmias in the heart failure patients. Heart’s ventricle contractions in arrhythmic patients are resynchronized by the CRT devices. CRT devices are the implantable devices with a microcomputer along with an enclosed battery by a tiny titanium metal case. Insulated wires known as leads are implanted along with the device so as to pass the information signals from the heart to heart device to carry electrical impulses to heart.

Increase in prevalence rate of the heart diseases globally driving the CRT devices market. Rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style driving the CRT devices market. Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. However, risks in CRT therapy such as surgical site infection, failure in delivering the optimum therapy when it is needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity towards the device material are hindering the growth of CRT devices market.

Global CRT Devices device market is segmented based on type of device, and end-user

Based on type of device, CRT market is segmented into

• CRT-pacemakers
• CRT-defibrillators

Based on end-user, CRT devices market is segmented into

• Hospitals
• Clinics
• Ambulatory Surgical Centres

CRT devices market is expected to show significant growth rate during forecast period due to the high prevalence of cardiac diseases. As per the World Health Organisation (WHO), one of the leading cause of death worldwide is cardiovascular disease, and around 17.5 Mn people died from the cardiovascular diseases which accounted 31% of all the global deaths in the year 2012. Cardiovascular diseases can be prevented by addressing the behavioural risks like cigarette smoking, an unhealthy diet and obesity, players in the market are focusing on the R&D investments to improve the product quality and to minimize manufacturing costs and also focus on development of the devices that are safe to improve compliance of the patient. For example, Medtronic and St. Jude Medical (Abbott laboratories) offer leadless pacemakers for the implantation of the equipment in the right ventricle. Moreover, increase in the usage of MRIs in clinical applications.

Geographically CRT Devices market is divided into five key regions they are North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be major contributor for CRT devices market owing to factors such as prevalence rates of heart diseases, well established healthcare infrastructure and increase in adaptability rates of CRT devices. Asia-Pacific and Latin American region are expected to witness lucrative growth owing to rapid expansion of industry players within these regions in terms of manufacturing as well as distribution. In addition, increased adaptability rates of a CRT devices and increase in awareness regarding CRT devices are expected to boost the market growth in this region.

Some of the players in the cardiac resynchronization therapy are Medtronic (U.S.), Abbott Laboratories (U.S.), Biotronik (Germany), LivaNova Plc. (UK), and Boston Scientific Corporation (U.S.) to name a few.

In February 2017, RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems was launched by Boston Scientific and also received CE Mark which is available for treatment of heart failure in patients across the globe

In January 2017, Abbott laboratories acquired St. Jude Medical, Inc., for the future growth and to develop a diverse and strong portfolio of medical devices, nutritionals, diagnostics and established branded generic pharmaceuticals.

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET INTRODUCTION

2.1. Global Cardiac Resynchronization Therapy (CRT Devices) Market – Taxonomy
2.2. Global Cardiac Resynchronization Therapy (CRT Devices) Market –Definitions
  2.2.1. Device Type
  2.2.2. End User

3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamic Factors - Impact Analysis

4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET, BY DEVICE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. CRT-pacemakers
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. CRT-defibrillators
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

6.1. Hospitals
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Clinics
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Ambulatory Surgical Centers
  6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

7.1. North America
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2017 – 2023

8. NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. CRT-pacemakers
  8.1.2. CRT-defibrillators
8.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.2.1. Hospitals
  8.2.2. Clinics
  8.2.3. Ambulatory Surgical Centres
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  8.3.1. U.S.
  8.3.2. Canada
8.4. North America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
8.5. North America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

9. EUROPE CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. CRT-pacemakers
  9.1.2. CRT-defibrillators
9.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.2.1. Hospitals
  9.2.2. Clinics
  9.2.3. Ambulatory Surgical Centres
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Germany
  9.3.2. UK
  9.3.3. France
  9.3.4. Spain
  9.3.5. Italy
  9.3.6. Russia
  9.3.7. Poland
  9.3.8. Rest of Europe
9.4. Europe Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
9.5. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

10. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. CRT-pacemakers
  10.1.2. CRT-defibrillators
10.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Hospitals
  10.2.2. Clinics
  10.2.3. Ambulatory Surgical Centres
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Japan
  10.3.2. China
  10.3.3. India
  10.3.4. ASEAN
  10.3.5. Australia & New Zealand
  10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
10.5. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

11. LATIN AMERICA CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. CRT-pacemakers
  11.1.2. CRT-defibrillators
11.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Hospitals
  11.2.2. Clinics
  11.2.3. Ambulatory Surgical Centres
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Brazil
  11.3.2. Mexico
  11.3.3. Argentina
  11.3.4. Venezuela
  11.3.5. Rest of Latin America
11.4. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
11.5. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

12. MIDDLE EAST AND AFRICA CARDIAC RESYNCHRONIZATION THERAPY (CRT DEVICES) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. CRT-pacemakers
  12.1.2. CRT-defibrillators
12.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Hospitals
  12.2.2. Clinics
  12.2.3. Ambulatory Surgical Centres
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Gulf Cooperation Council (GCC) Countries
  12.3.2. Israel
  12.3.3. South Africa
  12.3.4. Rest of MEA
12.4. MEA Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
12.5. MEA Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Medtronic (U.S.)
  13.2.2. Abbott Laboratories (U.S.)
  13.2.3. Biotronik (Germany)
  13.2.4. LivaNova Plc. (UK)
  13.2.5. Boston Scientific Corporation (U.S.)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS